WallStSmart
MRUS

Merus BV

NASDAQ: MRUS · HEALTHCARE · BIOTECHNOLOGY

$90.00
+0.00% today

Updated 2025-12-30

Market cap
$6.83B
P/E ratio
P/S ratio
120.59x
EPS (TTM)
$-5.28
Dividend yield
52W range
$33 – $97
Volume
1.3M

Merus BV (MRUS) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2012201320142015201620172018201920202021202220232024
Total assets$10.62M$17.16M$4.30M$38.81M$76.05M$236.11M$249.96M$263.38M$231.22M$456.60M$376.54M$455.49M$785.13M
Cash & equivalents
Current assets$9.09M$15.85M$3.27M$37.74M$74.80M$225.70M$223.79M$247.37M$217.99M$424.18M$306.44M$368.81M$569.07M
Total liabilities$3.32M$6.58M$8.63M$7.86M$40.26M$178.65M$144.87M$132.08M$128.95M$140.40M$129.49M$99.15M$134.77M
Current liabilities$1.98M$5.44M$7.09M$6.91M$8.15M$22.46M$33.14M$36.79M$46.75M$71.90M$78.93M$69.09M$87.08M
Long-term debt$819000.00$789000.00$525655.00$335493.00$0.00$0.00
Shareholder equity
Retained earnings$-18.70M$-32.46M$-49.57M$-69.30M$-112.84M$-200.93M$-259.45M$-314.60M$-400.11M$-466.93M$-598.12M$-753.06M$-968.39M
Accounts receivable$1.27M$1.02M$677318.00$10933.00$2.48M$3.78M$4.86M$2.65M$1.75M$6.67M$4.70M$3.98M$4.71M
Inventory$1.00$2.00$0.00$12.46M$1.00$-3.18M$1.00$7.43M$4.91M$9.31M$1.00
Goodwill$0.00$0.00$0.00$0.00

Frequently asked questions

What is Merus BV's revenue?

Merus BV's trailing twelve-month revenue is $56.61M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is MRUS?

In its most recent fiscal year, MRUS ran a gross margin of 37.15%, an operating margin of -752.96%, and a net margin of -595.93%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does MRUS generate?

MRUS produced $-187.50M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.